AIM
Aigen Investment Management Portfolio holdings
AUM
$730M
1-Year Return
13.63%
This Quarter Return
+6.44%
1 Year Return
+13.63%
3 Year Return
+38.05%
5 Year Return
+65.25%
10 Year Return
–
AUM
$784M
AUM Growth
+$4.05M
(+0.52%)
Cap. Flow
-$17.4M
Cap. Flow
% of AUM
-2.22%
Top 10 Holdings %
Top 10 Hldgs %
9.33%
Holding
1,213
New
436
Increased
138
Reduced
259
Closed
380
Top Buys
| 1 |
Visa
V
|
$11.6M |
| 2 |
Walmart
WMT
|
$9.05M |
| 3 |
Merck
MRK
|
$7.88M |
| 4 |
Cigna
CI
|
$6.77M |
| 5 |
Garmin
GRMN
|
$6.47M |
Top Sells
| 1 |
TSMC
TSM
|
$8.08M |
| 2 |
Delta Air Lines
DAL
|
$5.98M |
| 3 |
T-Mobile US
TMUS
|
$5.97M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
$5.84M |
| 5 |
VSLR
VIVINT SOLAR, INC.
VSLR
|
$5.59M |
Sector Composition
| 1 | Technology | 15.62% |
| 2 | Consumer Discretionary | 14.19% |
| 3 | Healthcare | 13.82% |
| 4 | Financials | 13.08% |
| 5 | Industrials | 11.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
526
Alaunos Therapeutics
TCRT
$4.27M
| $312K | 0.04% |
825
-377
| -31% | -$143K |
|
527
Adverum Biotechnologies
ADVM
$73.9M
| $311K | 0.04% |
+3,024
| New | +$311K |
|
528
Apellis Pharmaceuticals
APLS
$3.55B
| $311K | 0.04% |
+10,308
| New | +$311K |
|
529
Louisiana-Pacific
LPX
$6.9B
| $311K | 0.04% |
+10,535
| New | +$311K |
|
530
Bally's
BALY
$454M
| $310K | 0.04% |
11,795
-5,583
| -32% | -$147K |
|
531
Compugen
CGEN
$134M
| $309K | 0.04% |
19,009
-78,160
| -80% | -$1.27M |
|
532
Enova International
ENVA
$3.01B
| $309K | 0.04% |
18,866
-23,727
| -56% | -$389K |
|
533
E.W. Scripps
SSP
$261M
| $305K | 0.04% |
26,688
+1,290
| +5% | +$14.7K |
|
|
GRUB
534
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
| $305K | 0.04% |
+2,107
| New | +$305K |
|
535
Ionis Pharmaceuticals
IONS
$9.76B
| $304K | 0.04% |
6,398
-16,367
| -72% | -$778K |
|
|
HOLI
536
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
| $302K | 0.04% |
+27,327
| New | +$302K |
|
537
Affiliated Managers Group
AMG
$6.54B
| $301K | 0.04% |
+4,404
| New | +$301K |
|
538
Goldman Sachs BDC
GSBD
$1.31B
| $301K | 0.04% |
20,000
-19,618
| -50% | -$295K |
|
539
Dr. Reddy's Laboratories
RDY
$11.9B
| $301K | 0.04% |
+21,650
| New | +$301K |
|
540
CACI
CACI
$10.4B
| $300K | 0.04% |
+1,408
| New | +$300K |
|
541
Sempra
SRE
$52.9B
| $298K | 0.04% |
+5,042
| New | +$298K |
|
542
Canadian Natural Resources
CNQ
$63.2B
| $297K | 0.04% |
+37,879
| New | +$297K |
|
543
Cue Biopharma
CUE
$59.9M
| $297K | 0.04% |
+19,705
| New | +$297K |
|
544
Schlumberger
SLB
$53.4B
| $296K | 0.04% |
18,994
-112,651
| -86% | -$1.76M |
|
545
Incyte
INCY
$16.9B
| $295K | 0.04% |
3,285
-4,922
| -60% | -$442K |
|
|
CVET
546
DELISTED
Covetrus, Inc. Common Stock
CVET
| $294K | 0.04% |
+12,048
| New | +$294K |
|
547
Abercrombie & Fitch
ANF
$4.49B
| $293K | 0.04% |
+21,027
| New | +$293K |
|
548
EQT Corp
EQT
$32.2B
| $293K | 0.04% |
+22,660
| New | +$293K |
|
549
Hope Bancorp
HOPE
$1.43B
| $293K | 0.04% |
+38,600
| New | +$293K |
|
550
Northwest Bancshares
NWBI
$1.86B
| $292K | 0.04% |
31,729
-53,135
| -63% | -$489K |
|